Ocean Shore Holding Co. (NASDAQ:OSHC) shares moved down -0.07% in last trading session and ended the day at $17.42. OSHC has a return on assets of 0.70%. Ocean Shore Holding Co. (NASDAQ:OSHC) quarterly performance is 4.36%.
Ocean Shore Holding Co. (NASDAQ:OSHC) announced that its annual meeting of shareholders will be held at The Flander’s Hotel located at 719 East 11th Street, Ocean City, New Jersey on Wednesday, May 25, 2016 at 8:30 a.m.
CubeSmart (NYSE:CUBE) ended the last trading day at $31.89. Company weekly volatility is calculated as 1.88% and price to cash ratio as 89.09. CubeSmart (NYSE:CUBE) showed a weekly performance of -0.75%.
CubeSmart (NYSE:CUBE) has opened Austin’s first “net zero” commercial building — meaning it generates more solar energy than it consumes. The self-storage facility opened for business on March 22 and is located at 6130 E. Ben White Blvd., at the corner of East Ben White Boulevard and Montopolis Boulevard.
On 23 March, Host Hotels & Resorts, Inc. (NYSE:HST) shares moved down -1.82% and was closed at $16.18. HST EPS growth in last 5 year was 41.60%. Host Hotels & Resorts, Inc. (NYSE:HST) year to date (YTD) performance is 5.48%.
Host Hotels and Resorts Inc (NYSE:HST) declared a quarterly dividend. Shareholders of record on Thursday, March 31st will be given a dividend of 0.20 per share on Friday, April 15th. This represents a $0.80 dividend on an annualized basis and a yield of 4.94%. The ex-dividend date is Tuesday, March 29th.
Celldex Therapeutics, Inc. (NASDAQ:CLDX) shares moved down -8.23% in last trading session and ended the day at $3.57. CLDX has a return on assets of -34.40%. Celldex Therapeutics, Inc. (NASDAQ:CLDX) quarterly performance is -77.67%.
On 17 March, Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced that the Company and its collaborating investigators will present seven posters with new clinical and preclinical data at the American Association for Cancer Research (AACR) Annual Meeting 2016 in New Orleans.
Bellerophon Therapeutics LLC (NASDAQ:BLPH) caters to the Healthcare space. Its weekly performance is -21.57%. On the last day of trading company shares ended up at $2.40. Bellerophon Therapeutics LLC (NASDAQ:BLPH) distance from 50-day simple moving average (SMA50) is 17.23%.
On 21 March, Bellerophon Therapeutics LLC (NASDAQ:BLPH) said that, it receives final FDA confirmation to initiate phase 3 studies using next generation inopulse device
Leave a Reply